Biomedical Textiles Market

Biomedical Textiles Market: Overview

The Biomedical Textiles Market is valued at USD 18.1 Bn in 2026 and is projected to reach USD 27.6 Bn, growing at a CAGR of 6% by 2033. The demand for wound care products such as gauzes, plaster, and orthopedic implants will be a major driver accelerating the biomedical textiles market's growth rate. Another significant factor resulting in the market's growth is the senior population's expansion. Furthermore, the increasing number of surgeries and high-quality biomedical textiles are the major drivers that will expand the market's growth. Likewise, an increase in the number of chronic disorders and accidents and rapid urbanization will positively impact the market's growth rate. Increasing healthcare expenditure, changing lifestyles and a rise in disposable incomes in developing and developed countries will impact the growth rate of the biomedical textiles market.

Moreover, the increase in the development of smart biomedical textiles and advancement in medical technology will offer beneficial opportunities for the biomedical textiles market growth. Additionally, growing demand from emerging markets and rising awareness about health and hygiene will further expand the biomedical textiles market's growth during the forecast period. On the other hand, high R&D investment will hinder the market growth. Also, increasing pricing pressure on market players and product marketing will challenge the biomedical textiles market. However, the lack of healthcare professionals and less recognition will act as a restraint and further impede the market's growth rate.

The key players of the global biomedical textiles market adopt several strategies such as; partnerships, collaborations, and acquisitions to expand their global market reach. Players also make remarkable investments in R&D to add innovations to their products. For instance, in August 2021, TECNALIA announced its participation in developing printable and many biomedical electrodes. These are based on adaptable, smart fabric textiles. The company would manufacture electrodes with several elastic textile pads and integrated logic circuits, permitting flexible and adjustable placement. This initiative anticipates revolutionary advancements by integrating electronic devices with flexible biomedical electrodes based on wearable textile fibers. Furthermore, in July 2020, Secant Group announced that it had expanded biomaterial platform technology. It offers an implantable, resorbable polymer to fuel innovation in the pharma, medical device, and biopharma markets. The company aims to develop high-performance materials by combining traditional biomedical textiles with regenerative medicines to upgrade the quality of life. This initiative would assist innovative medical technology, and the newly introduced biomaterials are anticipated to be used in several additional areas, including novel implantable drug-delivery devices.

Growing Need for Advanced Wound Dressing Material to Drive Market Growth

Changing lifestyles, increasing disposable income, and growing awareness about health and hygiene have increased the demand for biomedical textiles with antibacterial, anti-fungal, and easy healing properties. According to a survey conducted by Dow Microbial Control, a business unit of The Dow Chemical Company (US), more than 60% of consumers demand advanced wound dressing materials to prevent dust, mold, and parasites bacterial, viral, and airborne infections. The survey also concluded that consumers purchase premium products to fulfill their requirements for wound dressing products with better performance.

Advancements in Healthcare Sector to Augment Market Growth

Due to growing healthcare budgets, increasing health awareness, and rising healthcare expenditure, the rising healthcare industry will likely drive the global biomedical textiles industry over the forecast period. Increasing cases of accidents, lifestyle diseases, and frequent infection spread propel the need for technological innovations to ease treatment processes, and thus, are anticipated to offer huge market scope for biomedical textile manufacturers in the healthcare industry. Furthermore, upcoming technology such as tissue engineering, wherein specially designed textiles can form a new tissue around them, which would allow the body not to depend solely on synthetic material for the implant, is expanding the popularity of biomedical textiles. The increasing geriatric population and the growing demand for wound care products such as; orthopedic implants and plaster casts are projected to expand the market growth in the forecast period. The surging chronic diseases, increasing road accidents, and the growing investment in the healthcare sector are other important factors bolstering the industry. Moreover, the ongoing development in technologies such as; tissue engineering is anticipated to further fuel the demand for biomedical textiles in the coming years.

High R&D Investments to Hamper Market Growth

Biomedical textiles are advanced materials that resist several bacteria, fungi, fire, dirt, and water. Developing these fabrics involves extensive R&D to provide specialized products that meet healthcare specifications. The R&D costs involved in high-end manufacturing fabrics are high, including labor, technological, and other related costs. The production of raw materials, including polyester, cotton, polypropylene, polyurethane, vinyl, and other fibers, involves complex processes that require heavy investments. These materials also need efficient machinery, the latest technology, and adequate supply. Raw materials utilized in antimicrobial biomedical textiles include various fibers and antimicrobial agents such as silver, copper, and quaternary ammonium, which are highly expensive. Moreover, players in the market must monitor the production of high-quality textiles as it is a complex process. Thus, the R&D investments needed in manufacturing these textiles are high, thereby hampering the market's growth.

Biomedical Textiles Market: Segment Overview

Increasing Surgeries to Grow Non-Implantable Biomedical Textiles Segment

The non-implantable biomedical textiles segment will dominate the global biomedical textile share during the forecast period. The expansion can be attributed to the increase in demand for non-implantable applications such as; tubular, gauze, adhesive, cohesive, and triangular bandages. The segment provides characteristics such as; softness, absorption, fit, absorption, and cost-effectiveness, which is anticipated to expand its demand in the forecast period. Furthermore, the increased number of accidents and surgeries is predicted to grow the demand for non-implantable textiles, fueling the market during the forecast period.

Increasing Applications of Non-Biodegradable Fibers in Soft & Hard Tissue Implants Drives Market Growth

The non-biodegradable fiber type segment is attributed to the largest growth and is also anticipated to grow at the highest CAGR during the forecast period. Non-biodegradable fibers are slowly soaked up by the body and take more than six months to break down. The segment of the non-biodegradable fiber type is due to the high consumption of non-biodegradable fibers, including polypropylene, polyethylene, viscose, polyamide, and polyester in several applications as surgical sutures, bandages, hard and soft tissue implants, and extracorporeal devices.

Growing Obese to Boost Biomedical Fabric Demand in North America

North America is expected to lead the global market due to key players and highly evolved healthcare centers. The increasing incidences of obesity are projected to expand the demand for biomedical textiles in several applications, thereby bolstering the market. As per the National Institutes of Health data, 10-15% of the US population suffers from gallstones in the bile duct, and nearly 5 million Americans suffer from valve-related heart diseases. The cure of such diseases demands advanced medical devices, including biomedical textiles. In addition, the high expenditures of the U.S to improve their healthcare sector is likely to fuel and present lucrative market opportunities for expansion during the forecast period.

The Asia-Pacific region is anticipated to be the fastest-growing market for biomedical textiles during the forecast period. Emerging markets are attributed in the APAC region, such as China, India, and Singapore, with increased health spending and the growth in disposable income driving the expansion of the biomedical textiles market in the region. Furthermore, the increasing expenditure for establishing technical textile factories will directly stimulate the call for the biomedical textiles market. For example, the Gujarat (India) state government intends to create a textile technical mission to attract an investment of $ 1.62 billion to establish 2,000 textile technical manufacturing facilities. Therefore, the growth in the call for technical textiles will directly influence the call for biomedical textiles in the region. Asia-Pacific is anticipated to be a very attractive market. Furthermore, the increasing number of healthcare centers to facilitate quality services is fueling the market's demand in the Asia Pacific.

In January 2022, Confluent Medical Technologies, a renowned name in offering biomedical textile services, announced that TPG Capital would majorly invest in the company. Moreover, in January 2022, the Johnson & Johnson Medical Devices Companies (JJMDC) announced that it would collaborate with Microsoft to enable and increase JJMDC's compliant digital surgery ecosystem. Additionally, in January 2018, Medtronic plc launched the new SynchroMed(TM) II Intrathecal Drug Delivery system, an implantable pump that offers targeted drug delivery for chronic pain and severe spasticity. The SynchroMed II pump provides medication directly to the fluid around the spinal cord.

Few of the players in the Biomedical Textiles Market include:

• Congluent Medical Technologies, Inc.
• Atex Technologies, Inc.
• Secant Medical, LLC
• Swicofil AG
• Bally Ribbon Mills (BRM)
• Hartmann USA, Inc.
• Medline Industries, LP
• Proxy Biomedical Limited
• US BioDesign, Inc.

Global Biomedical Textiles Market is Segmented as-

By Fabric Type
• Woven
• Non-Woven
• Other

By Fiber
• Biodegradable
• Non Biodegradable

By Category
• Implantable Material
• Non-Implantable Material
• Extracorporeal Implants
• Other

By Product Application
• General Surgery
• Cardiology
• Orthopedics
• Cosmetics
• Dental
• Tissue Engineering
• Other

By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa